Why Adults Living with HIV Are at High Risk for Diabetes

Immunocore Q2 Earnings Call Highlights

Immunocore (NASDAQ:IMCR) reported continued growth for KIMMTRAK in the second quarter and first half of 2026, while advancing three late-stage melanoma trials and early-stage programs in oncology, HIV and Type 1 diabetes. The company recorded $223 million in KIMMTRAK net sales during the first half

Montreal researchers develop new method for liver fibrosis screening among HIV patients

Researchers at the McGill University Health Centre (MUHC) in Montreal have developed a new method for screening for liver fibrosis among HIV patients which they say are more effective compared to the commonly used test. Liver fibrosis which is the build-up of scar tissue in the liver can lead to permanent damage and is one […]

Why adults living with HIV are at high risk for diabetes

A new UC San Francisco study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.

New research highlights hidden metabolic risks in non-obese HIV patients

A new UC San Francisco study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.